What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...